Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
3. EU allows GI Dynamics EndoBarrier back on the market
European regulators cleared GI Dynamics to resume sales of its EndoBarrier weight loss device, now that the Massachusetts company resolved concerns over use guidelines and how it reports adverse events.
EndoBarrier is a plastic lining delivered endoscopically into the small intestine, designed to treat obesity and Type II diabetes by slowing the absorption of nutrients into the body. Read more
2. EU regulators clear Medtronic’s Covidien buy
Medtronic said that its proposed, $43 billion acquisition of Covidien cleared anti-trust hurdles in the Europe.
The approval, announced Nov. 28, came 2 days after the U.S. Federal Trade Commission granted its benison for the deal. Read more
1. FTC gives Medtronic, Covidien merger the green light
The U.S. Federal Trade Commission has approved the pending $43 billion merger between Medtronic and Covidien, according to regulatory filings.
“This regulatory clearance represents an important milestone in bringing our companies together,” said Omar Ishrak, Chairman and CEO of Medtronic in a prepared release. Read more
